Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway

A classical acute porphyria model in rats consists of combined treatment with 2-allyl-2-isopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The present work describes the effects of this treatment on the pentose phosphate (PP) pathway, glutahione metabolism and redox state...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2013
Materias:
rat
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15353702_v238_n2_p133_Faut
http://hdl.handle.net/20.500.12110/paper_15353702_v238_n2_p133_Faut
Aporte de:
id paper:paper_15353702_v238_n2_p133_Faut
record_format dspace
spelling paper:paper_15353702_v238_n2_p133_Faut2023-06-08T16:20:06Z Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway Glucose-6-phosphate dehydrogenase Glutathione metabolism Pentose phosphate pathway Porphyria Rat liver Reactive oxygen species 5 aminolevulinate synthase glucose glucose 6 phosphate dehydrogenase glutathione glutathione disulfide glutathione peroxidase glutathione reductase glutathione transferase heme phosphogluconate dehydrogenase pyridine nucleotide reactive oxygen metabolite acute intermittent porphyria animal experiment animal model animal tissue article blood sampling controlled study DNA damage enzyme linked immunosorbent assay female glutathione metabolism nonhuman oxidation reduction state oxidative stress pentose phosphate cycle protein determination rat spectrophotometry urinalysis Allylisopropylacetamide Animals Disease Models, Animal Glucose Glucosephosphate Dehydrogenase Glutathione Glutathione Disulfide Glutathione Peroxidase Glutathione Reductase Glutathione Transferase Heme Liver NADP Oxidation-Reduction Oxidative Stress Pentose Phosphate Pathway Porphyria, Acute Intermittent Pyridines Rats Reactive Oxygen Species A classical acute porphyria model in rats consists of combined treatment with 2-allyl-2-isopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The present work describes the effects of this treatment on the pentose phosphate (PP) pathway, glutahione metabolism and redox state and how they contribute to alter the glucose pool of hepatocytes and modulate porphyria, in Wistar rat livers. Our approach is based on the fact that glucose is a repressor of 5-aminolevulinic synthase (ALA-S), the rate-limiting enzyme of the heme pathway, and treatment with AIA/DCC causes oxidative stress. Different doses of the xenobiotcs were used. The results show that AIA (500 mg/kg body weight [BW])/ DDC (50 mg/kg [BW]) treatment increased glutathione peroxidase (GPx) activity by 46%, decreased both glutathione reductase (GR) and glutathione S-transferase (GST) activity by 69% and 52%, respectively, and reduced by 51% reduced glutathione (GSH) and increased by 100% glutathione disulfide (GSSG) concentrations, therefore lowering by four-fold the GSH/GSSG ratio. The activity of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of PP-pathway, was increased by 129% as well as that of 6-phosphogluconate dehydrogenase. NADPH and the NADPH/NADP+ ratio were increased by 14% and 28%, respectively. These effects could be attributed to the generation of reactive oxygen species (ROS) elicited by the porphyrinogenic treatment, shown by enhanced DNA damage and ROS production. G6PD stimulation would decrease hepatic glucose concentrations and consequently exacerbate the porphyria. A decrease in glucose could stimulate ALA-S and this would add to the effect of drug-induced heme depletion. Since the key role of GST is to inactivate toxic compounds, the drastic fall in its activity together with the accumulation of ALA would account for the symptoms of this hepatic disease model. The present findings show the high metabolic interplay between pathways and constitute a relevant contribution to achieve a better treatment of acute human porphyria. © 2013 by the Society for Experimental Biology and Medicine. 2013 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15353702_v238_n2_p133_Faut http://hdl.handle.net/20.500.12110/paper_15353702_v238_n2_p133_Faut
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Glucose-6-phosphate dehydrogenase
Glutathione metabolism
Pentose phosphate pathway
Porphyria
Rat liver
Reactive oxygen species
5 aminolevulinate synthase
glucose
glucose 6 phosphate dehydrogenase
glutathione
glutathione disulfide
glutathione peroxidase
glutathione reductase
glutathione transferase
heme
phosphogluconate dehydrogenase
pyridine nucleotide
reactive oxygen metabolite
acute intermittent porphyria
animal experiment
animal model
animal tissue
article
blood sampling
controlled study
DNA damage
enzyme linked immunosorbent assay
female
glutathione metabolism
nonhuman
oxidation reduction state
oxidative stress
pentose phosphate cycle
protein determination
rat
spectrophotometry
urinalysis
Allylisopropylacetamide
Animals
Disease Models, Animal
Glucose
Glucosephosphate Dehydrogenase
Glutathione
Glutathione Disulfide
Glutathione Peroxidase
Glutathione Reductase
Glutathione Transferase
Heme
Liver
NADP
Oxidation-Reduction
Oxidative Stress
Pentose Phosphate Pathway
Porphyria, Acute Intermittent
Pyridines
Rats
Reactive Oxygen Species
spellingShingle Glucose-6-phosphate dehydrogenase
Glutathione metabolism
Pentose phosphate pathway
Porphyria
Rat liver
Reactive oxygen species
5 aminolevulinate synthase
glucose
glucose 6 phosphate dehydrogenase
glutathione
glutathione disulfide
glutathione peroxidase
glutathione reductase
glutathione transferase
heme
phosphogluconate dehydrogenase
pyridine nucleotide
reactive oxygen metabolite
acute intermittent porphyria
animal experiment
animal model
animal tissue
article
blood sampling
controlled study
DNA damage
enzyme linked immunosorbent assay
female
glutathione metabolism
nonhuman
oxidation reduction state
oxidative stress
pentose phosphate cycle
protein determination
rat
spectrophotometry
urinalysis
Allylisopropylacetamide
Animals
Disease Models, Animal
Glucose
Glucosephosphate Dehydrogenase
Glutathione
Glutathione Disulfide
Glutathione Peroxidase
Glutathione Reductase
Glutathione Transferase
Heme
Liver
NADP
Oxidation-Reduction
Oxidative Stress
Pentose Phosphate Pathway
Porphyria, Acute Intermittent
Pyridines
Rats
Reactive Oxygen Species
Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
topic_facet Glucose-6-phosphate dehydrogenase
Glutathione metabolism
Pentose phosphate pathway
Porphyria
Rat liver
Reactive oxygen species
5 aminolevulinate synthase
glucose
glucose 6 phosphate dehydrogenase
glutathione
glutathione disulfide
glutathione peroxidase
glutathione reductase
glutathione transferase
heme
phosphogluconate dehydrogenase
pyridine nucleotide
reactive oxygen metabolite
acute intermittent porphyria
animal experiment
animal model
animal tissue
article
blood sampling
controlled study
DNA damage
enzyme linked immunosorbent assay
female
glutathione metabolism
nonhuman
oxidation reduction state
oxidative stress
pentose phosphate cycle
protein determination
rat
spectrophotometry
urinalysis
Allylisopropylacetamide
Animals
Disease Models, Animal
Glucose
Glucosephosphate Dehydrogenase
Glutathione
Glutathione Disulfide
Glutathione Peroxidase
Glutathione Reductase
Glutathione Transferase
Heme
Liver
NADP
Oxidation-Reduction
Oxidative Stress
Pentose Phosphate Pathway
Porphyria, Acute Intermittent
Pyridines
Rats
Reactive Oxygen Species
description A classical acute porphyria model in rats consists of combined treatment with 2-allyl-2-isopropylacetamide (AIA) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). The present work describes the effects of this treatment on the pentose phosphate (PP) pathway, glutahione metabolism and redox state and how they contribute to alter the glucose pool of hepatocytes and modulate porphyria, in Wistar rat livers. Our approach is based on the fact that glucose is a repressor of 5-aminolevulinic synthase (ALA-S), the rate-limiting enzyme of the heme pathway, and treatment with AIA/DCC causes oxidative stress. Different doses of the xenobiotcs were used. The results show that AIA (500 mg/kg body weight [BW])/ DDC (50 mg/kg [BW]) treatment increased glutathione peroxidase (GPx) activity by 46%, decreased both glutathione reductase (GR) and glutathione S-transferase (GST) activity by 69% and 52%, respectively, and reduced by 51% reduced glutathione (GSH) and increased by 100% glutathione disulfide (GSSG) concentrations, therefore lowering by four-fold the GSH/GSSG ratio. The activity of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of PP-pathway, was increased by 129% as well as that of 6-phosphogluconate dehydrogenase. NADPH and the NADPH/NADP+ ratio were increased by 14% and 28%, respectively. These effects could be attributed to the generation of reactive oxygen species (ROS) elicited by the porphyrinogenic treatment, shown by enhanced DNA damage and ROS production. G6PD stimulation would decrease hepatic glucose concentrations and consequently exacerbate the porphyria. A decrease in glucose could stimulate ALA-S and this would add to the effect of drug-induced heme depletion. Since the key role of GST is to inactivate toxic compounds, the drastic fall in its activity together with the accumulation of ALA would account for the symptoms of this hepatic disease model. The present findings show the high metabolic interplay between pathways and constitute a relevant contribution to achieve a better treatment of acute human porphyria. © 2013 by the Society for Experimental Biology and Medicine.
title Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
title_short Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
title_full Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
title_fullStr Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
title_full_unstemmed Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
title_sort alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway
publishDate 2013
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15353702_v238_n2_p133_Faut
http://hdl.handle.net/20.500.12110/paper_15353702_v238_n2_p133_Faut
_version_ 1768543005130620928